This inventor holds 11 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Vaxinnate Corporation, Purdue Pharma L.p.. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cranbury, NJ (US) (2015)
- Princeton, NJ (US) (2013 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: Lynda G Tussey - Innovator in T-Cell Immune Response
Introduction
Lynda G Tussey is a prominent inventor based in Cranbury, NJ (US), known for her significant contributions to the field of immunology. She holds a total of 11 patents, showcasing her innovative approach to enhancing T-cell immune responses.
Latest Patents
Her latest patents focus on MHC-I restricted epitopes containing non-natural amino acid residues. The invention provides for the synthesis of more effective generators of a T-cell immune response by offering peptide derivatives that are MHC class I-restricted antigens. These peptide derivatives are derived from a parent peptide of 8 to 11 amino acid residues in length, wherein the peptide derivative contains a non-natural amino acid substituted in place of a naturally-occurring amino acid residue at one or more primary anchor positions in the parent peptide or at position 6, position 7, or the C-terminus.
Career Highlights
Throughout her career, Lynda has worked with notable companies such as Vaxinnate Corporation and Purdue Pharma L.P. Her work has significantly impacted the development of immunotherapeutic strategies.
Collaborations
Lynda has collaborated with esteemed colleagues, including Langzhou Song and Ge Liu, contributing to advancements in her field through teamwork and shared expertise.
Conclusion
Lynda G Tussey's innovative work in
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile